A Study of PD1 Combined With Dc-cik in the Treatment of Solid Tumors
Status:
Unknown status
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
This is a single center、single arm、open-label, to investigate the safety and efficacy of PD-1
and DC-CIK with anti-solid tumor
Phase:
Early Phase 1
Details
Lead Sponsor:
Allife Medical Science and Technology Co., Ltd.
Collaborators:
Beijing Hospital Henan Provincial People's Hospital The First People's Hospital of Yunnan Province/First People's Hospital of Yunan Provinve New Kunhua Hospital